A survey of current trends in computational drug repositioning.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 25832646)

Published in Brief Bioinform on March 31, 2015

Authors

Jiao Li, Si Zheng, Bin Chen, Atul J Butte, S Joshua Swamidass, Zhiyong Lu

Articles citing this

Assessing the state of the art in biomedical relation extraction: overview of the BioCreative V chemical-disease relation (CDR) task. Database (Oxford) (2016) 1.28

The road to precision psychiatry: translating genetics into disease mechanisms. Nat Neurosci (2016) 0.95

ksRepo: a generalized platform for computational drug repositioning. BMC Bioinformatics (2016) 0.82

A genomics-based systems approach towards drug repositioning for rheumatoid arthritis. BMC Genomics (2016) 0.82

Translational Bioinformatics: Past, Present, and Future. Genomics Proteomics Bioinformatics (2016) 0.78

A standard database for drug repositioning. Sci Data (2017) 0.77

Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases. Gastroenterology (2016) 0.76

Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations. J Cheminform (2016) 0.76

Predictive Modeling of Drug Treatment in the Area of Personalized Medicine. Cancer Inform (2015) 0.76

Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing. Sci Rep (2016) 0.76

A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase. Sci Rep (2017) 0.75

Use of big data in drug development for precision medicine. Expert Rev Precis Med Drug Dev (2016) 0.75

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. Alzheimers Res Ther (2017) 0.75

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System. J Vis Exp (2016) 0.75

Drug-target interaction prediction via class imbalance-aware ensemble learning. BMC Bioinformatics (2016) 0.75

Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks. BMC Bioinformatics (2016) 0.75

Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology. Int J Mol Sci (2016) 0.75

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov. PeerJ (2017) 0.75

Drug voyager: a computational platform for exploring unintended drug action. BMC Bioinformatics (2017) 0.75

DIGNiFI: Discovering causative genes for orphan diseases using protein-protein interaction networks. BMC Syst Biol (2017) 0.75

A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network. Biomed Res Int (2016) 0.75

Prediction of new drug indications based on clinical data and network modularity. Sci Rep (2016) 0.75

DrugSig: A resource for computational drug repositioning utilizing gene expression signatures. PLoS One (2017) 0.75

VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization. BMC Bioinformatics (2017) 0.75

A Simple Text Mining Approach for Ranking Pairwise Associations in Biomedical Applications. AMIA Jt Summits Transl Sci Proc (2017) 0.75

Articles cited by this

(truncated to the top 100)

The Protein Data Bank. Nucleic Acids Res (2000) 187.10

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (2006) 25.99

NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res (2005) 17.61

Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74

Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91

How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov (2010) 14.09

Drug-target network. Nat Biotechnol (2007) 11.15

Predicting new molecular targets for known drugs. Nature (2009) 9.71

A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol (2010) 6.75

Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature (2013) 6.57

Molecular networks as sensors and drivers of common human diseases. Nature (2009) 6.14

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85

Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci U S A (2010) 4.35

Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun (2013) 4.35

PubMed and beyond: a survey of web tools for searching biomedical literature. Database (Oxford) (2011) 3.68

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina (2006) 3.48

Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2014) 3.36

Understanding PubMed user search behavior through log analysis. Database (Oxford) (2009) 3.27

PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol (2011) 3.22

PubTator: a web-based text mining tool for assisting biocuration. Nucleic Acids Res (2013) 3.02

DNorm: disease name normalization with pairwise learning to rank. Bioinformatics (2013) 2.83

Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform (2011) 2.52

Use of genome-wide association studies for drug repositioning. Nat Biotechnol (2012) 2.51

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov (2013) 2.46

Infectious diseases. Debate erupts on 'repurposed' drugs for Ebola. Science (2014) 2.14

tmChem: a high performance approach for chemical named entity recognition and normalization. J Cheminform (2015) 1.96

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia. Cancer Discov (2013) 1.93

PROMISCUOUS: a database for network-based drug-repositioning. Nucleic Acids Res (2010) 1.69

Repositioning metformin for cancer prevention and treatment. Trends Endocrinol Metab (2013) 1.68

Drug-induced regulation of target expression. PLoS Comput Biol (2010) 1.65

Prospects for productivity. Nat Rev Drug Discov (2004) 1.65

Systematic drug repositioning based on clinical side-effects. PLoS One (2011) 1.56

Literature mining, ontologies and information visualization for drug repurposing. Brief Bioinform (2011) 1.51

Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS One (2013) 1.50

Old drugs, new tricks. BMJ (2011) 1.48

A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med (2013) 1.47

Transcriptional data: a new gateway to drug repositioning? Drug Discov Today (2012) 1.40

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer. Cancer (2011) 1.32

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. J Am Med Inform Assoc (2014) 1.25

Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors. Proc Natl Acad Sci U S A (2014) 1.25

Drug repositioning for personalized medicine. Genome Med (2012) 1.24

BioCreative-IV virtual issue. Database (Oxford) (2014) 1.23

DCDB: drug combination database. Bioinformatics (2009) 1.21

The cost of new drug discovery and development. Discov Med (2004) 1.21

Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases. Brief Bioinform (2011) 1.17

Assessing drug target association using semantic linked data. PLoS Comput Biol (2012) 1.14

Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci (2014) 1.12

Drug repositioning: a machine-learning approach through data integration. J Cheminform (2013) 1.11

A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Res (2011) 1.09

SM2miR: a database of the experimentally validated small molecules' effects on microRNA expression. Bioinformatics (2012) 1.08

A New Method for Computational Drug Repositioning Using Drug Pairwise Similarity. Proceedings (IEEE Int Conf Bioinformatics Biomed) (2012) 1.05

The challenges, advantages and future of phenome-wide association studies. Immunology (2014) 1.04

Pathway-based drug repositioning using causal inference. BMC Bioinformatics (2013) 1.04

DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data. Bioinformatics (2012) 1.04

Systematic identification of pharmacogenomics information from clinical trials. J Biomed Inform (2012) 1.03

LabeledIn: cataloging labeled indications for human drugs. J Biomed Inform (2014) 1.02

Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proc Natl Acad Sci U S A (2010) 1.00

Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development. Front Oncol (2013) 0.98

Scaling drug indication curation through crowdsourcing. Database (Oxford) (2015) 0.97

MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT). Chin J Cancer (2013) 0.95

Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med (2012) 0.93

Linking PharmGKB to phenotype studies and animal models of disease for drug repurposing. Pac Symp Biocomput (2012) 0.93

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer. J Cancer Res Clin Oncol (2013) 0.93

e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics (2012) 0.92

Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Sci Rep (2012) 0.92

Pharmaco-miR: linking microRNAs and drug effects. Brief Bioinform (2013) 0.92

Mining small-molecule screens to repurpose drugs. Brief Bioinform (2011) 0.90

Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity. AMIA Annu Symp Proc (2014) 0.89

Drug repurposing for gastrointestinal stromal tumor. Mol Cancer Ther (2013) 0.89

Computational and experimental advances in drug repositioning for accelerated therapeutic stratification. Curr Top Med Chem (2015) 0.88

Large-scale integration of small molecule-induced genome-wide transcriptional responses, Kinome-wide binding affinities and cell-growth inhibition profiles reveal global trends characterizing systems-level drug action. Front Genet (2014) 0.88

Computational repositioning and preclinical validation of pentamidine for renal cell cancer. Mol Cancer Ther (2014) 0.87

IDMap: facilitating the detection of potential leads with therapeutic targets. Bioinformatics (2008) 0.86

MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer. Am J Clin Exp Urol (2014) 0.86

Drug repositioning by kernel-based integration of molecular structure, molecular activity, and phenotype data. PLoS One (2013) 0.85

Systematic drug repurposing through text mining. Methods Mol Biol (2014) 0.84

Construction of drug network based on side effects and its application for drug repositioning. PLoS One (2014) 0.84

Systematic prediction of drug combinations based on clinical side-effects. Sci Rep (2014) 0.84

Characteristics of drug combination therapy in oncology by analyzing clinical trial data on ClinicalTrials.gov. Pac Symp Biocomput (2015) 0.84

Computational drug repositioning through heterogeneous network clustering. BMC Syst Biol (2013) 0.84

Network based elucidation of drug response: from modulators to targets. BMC Syst Biol (2013) 0.83

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity. Mol Biosyst (2014) 0.82

Disease genetics: phenome-wide association studies go large. Nat Rev Genet (2013) 0.81

Identification of drug combinations containing imatinib for treatment of BCR-ABL+ leukemias. PLoS One (2014) 0.81

Drug-disease association and drug-repositioning predictions in complex diseases using causal inference-probabilistic matrix factorization. J Chem Inf Model (2014) 0.80

Anti-infectious drug repurposing using an integrated chemical genomics and structural systems biology approach. Pac Symp Biocomput (2014) 0.79

Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies. Curr Top Med Chem (2013) 0.79

Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging Web ontology language (OWL) and cheminformatics approaches. Pac Symp Biocomput (2014) 0.78

A phenome-guided drug repositioning through a latent variable model. BMC Bioinformatics (2014) 0.78

Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching. J Med Chem (2013) 0.78

The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling. Cancer (2012) 0.77

Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA (2014) 0.77

Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis. Genome Med (2014) 0.77

Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs). BMC Bioinformatics (2013) 0.77

The year's new drugs & biologics, 2013: Part I. Drugs Today (Barc) (2014) 0.77

A hadoop-based method to predict potential effective drug combination. Biomed Res Int (2014) 0.76

MicroRNAs and anticancer drugs. Acta Biochim Biophys Sin (Shanghai) (2014) 0.76

Articles by these authors

(truncated to the top 100)

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2009) 12.51

Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2010) 10.97

Clinical assessment incorporating a personal genome. Lancet (2010) 10.18

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2011) 8.62

Performance comparison of exome DNA sequencing technologies. Nat Biotechnol (2011) 7.11

Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07

Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol (2012) 6.38

Ontology-driven indexing of public datasets for translational bioinformatics. BMC Bioinformatics (2009) 6.31

Performance comparison of whole-genome sequencing platforms. Nat Biotechnol (2011) 5.79

Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med (2011) 5.77

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30

Overview of BioCreative II gene normalization. Genome Biol (2008) 5.05

Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75

An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One (2010) 4.42

Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones (2008) 4.30

Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol (2012) 3.62

Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet (2009) 3.59

FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell (2009) 3.54

Understanding PubMed user search behavior through log analysis. Database (Oxford) (2009) 3.27

Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A (2012) 3.27

Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol (2010) 3.23

Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet (2011) 3.20

The Protein-Protein Interaction tasks of BioCreative III: classification/ranking of articles and linking bio-ontology concepts to full text. BMC Bioinformatics (2011) 3.03

PubTator: a web-based text mining tool for assisting biocuration. Nucleic Acids Res (2013) 3.02

Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92

DNorm: disease name normalization with pairwise learning to rank. Bioinformatics (2013) 2.83

Systematic survey reveals general applicability of "guilt-by-association" within gene coexpression networks. BMC Bioinformatics (2005) 2.83

OpenDMAP: an open source, ontology-driven concept analysis engine, with applications to capturing knowledge regarding protein transport, protein interactions and cell-type-specific gene expression. BMC Bioinformatics (2008) 2.81

The dragon strikes: lessons from the Wenchuan earthquake. Anesth Analg (2010) 2.78

The determination of projection neuron identity in the developing cerebral cortex. Curr Opin Neurobiol (2008) 2.77

Recommending MeSH terms for annotating biomedical articles. J Am Med Inform Assoc (2011) 2.77

Malaria in the Greater Mekong Subregion: heterogeneity and complexity. Acta Trop (2011) 2.70

BioC: a minimalist approach to interoperability for biomedical text processing. Database (Oxford) (2013) 2.69

Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol (2005) 2.68

Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell (2008) 2.67

Computerized recruiting for clinical trials in real time. Ann Emerg Med (2003) 2.59

Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform (2011) 2.52

Exome sequencing identifies ZNF644 mutations in high myopia. PLoS Genet (2011) 2.52

Quantifying the relationship between co-expression, co-regulation and gene function. BMC Bioinformatics (2004) 2.51

Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50

AILUN: reannotating gene expression data automatically. Nat Methods (2007) 2.47

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov (2013) 2.46

MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev (2009) 2.44

Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int J Epidemiol (2012) 2.42

Translational bioinformatics: linking knowledge across biological and clinical realms. J Am Med Inform Assoc (2011) 2.36

Overview of the BioCreative III Workshop. BMC Bioinformatics (2011) 2.31

Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet (2010) 2.24

Reproducibility of gene expression across generations of Affymetrix microarrays. BMC Bioinformatics (2003) 2.20

A nutrient-wide association study on blood pressure. Circulation (2012) 2.19

Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer. J Natl Cancer Inst (2003) 2.18

Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev (2004) 2.16

ChemDB: a public database of small molecules and related chemoinformatics resources. Bioinformatics (2005) 2.16

BioCreative III interactive task: an overview. BMC Bioinformatics (2011) 2.16

The safety and efficacy of minimally invasive discectomy: a meta-analysis of prospective randomised controlled trials. Int Orthop (2014) 2.11

Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PLoS One (2010) 2.10

Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica (2007) 2.07

Network environ perspective for urban metabolism and carbon emissions: a case study of Vienna, Austria. Environ Sci Technol (2012) 2.06

Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nat Genet (2012) 2.02

Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet (2009) 1.96

De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci U S A (2002) 1.95

Life-cycle energy production and emissions mitigation by comprehensive biogas-digestate utilization. Bioresour Technol (2012) 1.94

Disease signatures are robust across tissues and experiments. Mol Syst Biol (2009) 1.93

Concept recognition for extracting protein interaction relations from biomedical text. Genome Biol (2008) 1.93

Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo. J Natl Cancer Inst (2003) 1.92

Semi-automatic semantic annotation of PubMed queries: a study on quality, efficiency, satisfaction. J Biomed Inform (2010) 1.91

Evaluation of lexical methods for detecting relationships between concepts from multiple ontologies. Pac Symp Biocomput (2006) 1.90

Accelerating literature curation with text-mining tools: a case study of using PubTator to curate genes in PubMed abstracts. Database (Oxford) (2012) 1.89

tmVar: a text mining approach for extracting sequence variants in biomedical literature. Bioinformatics (2013) 1.87

Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci (2003) 1.87

Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell (2004) 1.87

ChemDB update--full-text search and virtual chemical space. Bioinformatics (2007) 1.83

An overview of the BioCreative 2012 Workshop Track III: interactive text mining task. Database (Oxford) (2013) 1.82

In silico research in the era of cloud computing. Nat Biotechnol (2010) 1.81

Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during neocortical development. J Neurosci (2011) 1.81

The post-stishovite phase transition in hydrous alumina-bearing SiO2 in the lower mantle of the earth. Proc Natl Acad Sci U S A (2007) 1.80

Population genetic inference from personal genome data: impact of ancestry and admixture on human genomic variation. Am J Hum Genet (2012) 1.75

Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care (2013) 1.70

Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int (2009) 1.68

Stent graft-induced new entry after endovascular repair for Stanford type B aortic dissection. J Vasc Surg (2010) 1.62

Translational bioinformatics in the cloud: an affordable alternative. Genome Med (2010) 1.61

Enabling integrative genomic analysis of high-impact human diseases through text mining. Pac Symp Biocomput (2008) 1.61

FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease. Genome Biol (2008) 1.58

SR4GN: a species recognition software tool for gene normalization. PLoS One (2012) 1.57

Posterior unilateral pedicle subtraction osteotomy of hemivertebra for correction of the adolescent congenital spinal deformity. Spine J (2010) 1.56

Identification of complex metabolic states in critically injured patients using bioinformatic cluster analysis. Crit Care (2010) 1.55

Predicting environmental chemical factors associated with disease-related gene expression data. BMC Med Genomics (2010) 1.55

Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. PLoS Genet (2012) 1.55

Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes. Proc Natl Acad Sci U S A (2005) 1.55

Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52

Tuberous sclerosis complex: renal imaging findings. Radiology (2002) 1.51

ImmPort: disseminating data to the public for the future of immunology. Immunol Res (2014) 1.48

Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus. Hum Genet (2013) 1.48

Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A (2009) 1.47

A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med (2013) 1.47

Proteome Analyst: custom predictions with explanations in a web-based tool for high-throughput proteome annotations. Nucleic Acids Res (2004) 1.46

Factors associated with smoking cessation among Chinese adults in rural China. Am J Health Behav (2008) 1.43

Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 1.42

Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J Chem Inf Model (2009) 1.40